FindTrial
Sign In

Cervical cancer screening using Smart Scope in primary health centers

Interventional study to augment implementation of cervical cancer prevention strategy in Primary Health Centers using Smart Scope® - PHC-Smart Scope

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046849
Enrollment
50
Registered
2022-10-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: augmented visual examination test using Smart Scope: Using Smart Scope®, a portable, made in India transvaginal device as enabler to the health care providers in PHCs (interventional g

Sponsors

Periwinkle Technologies Pvt Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Kindly note: In this study, the participants are the healthcare providers at the PHCs. consenting healthcare providers (MO/RMA/Staff Nurse) working in PHCs of Raipur district Screening participants: Sexually active Women aged 30-65 residing in the area catered by the study PHCs

Exclusion criteria

Exclusion criteria: Study participants:Healthcare providers who are not trained in cervical cancer screening procedure Screening participants:pregnant women

Design outcomes

Primary

MeasureTime frame
â?¢ Improvement in understanding and confidence level among healthcare workers in interpreting VIA and choosing the correct lesion for ablative therapy. â?¢ Sustainability of knowledge on cervical cancer screening and treatment of pre-cancer augmented by continuous mentoring through hub and spoke model. Timepoint: â?¢ Improvement in understanding and confidence level among healthcare workers in interpreting VIA and choosing the correct lesion for ablative therapy. baseline/ 12/24/36 months â?¢ Sustainability of knowledge on cervical cancer screening and treatment of pre-cancer augmented by continuous mentoring through hub and spoke model.(12/24/36 months)—

Secondary

MeasureTime frame
Increase in screening coverage. â?¢ Increase in treatment of eligible pre-cancer lesion at the PHC level â?¢ Reduction in loss-to follow-up of patients â?¢ Reduced burden of referrals to the higher centers â?¢ Repository of VIA images Timepoint: Increase in screening coverage. â?¢ Increase in treatment of eligible pre-cancer lesion at the PHC level (12/24/36 months) â?¢ Reduction in loss-to follow-up of patients (12/24/36 months) â?¢ Reduced burden of referrals to the higher centers(12/24/36 months) â?¢ Repository of VIA images (36 months)—

Countries

India

Contacts

Public ContactKavitha Dhanasekaran

ICMR-National Institute of Cancer Prevention and Research

kavithad.dr@gmail.com8178218414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026